INS-PROSTATE CANCER SCREENING

Amends the Illinois Insurance Code. In provisions concerning cancer screenings, provides that a group policy of accident and health insurance that provides coverage for hospital or medical treatment or services for illness on an expense-incurred basis and is amended, delivered, issued, or renewed after the effective date of the amendatory Act shall provide coverage without imposing a deductible, coinsurance, copayment, or any other cost-sharing requirement on the benefits. Provides for coverage for an annual prostate cancer screening for male insureds. Defines "prostate cancer screening" as medically viable methods for the detection and diagnosis of prostate cancer, including a digital rectal exam and the prostate-specific antigen test and associated laboratory work, and provides that the term includes subsequent follow-up testing as directed by a health care provider, including, but not limited to, urinary analysis, serum biomarkers, and medical imaging. House Floor Amendment No. 1 Replaces everything after the enacting clause with the provisions of the introduced bill with the following changes. Provides that a group policy of accident and health insurance that provides coverage for hospital or medical treatment or services for illness on an expense-incurred basis and is amended, delivered, issued, or renewed after January 1, 2024 (rather than the effective date of the amendatory Act) shall provide coverage, without imposing a deductible, coinsurance, copayment, or any other cost-sharing requirement, for specified methods of cancer testing. Specifies that the provisions do not apply to coverage of prostate cancer screenings to the extent such coverage would disqualify a high-deductible health plan from eligibility for a health savings account under the Internal Revenue Code. Defines "prostate cancer screening" to include medically necessary subsequent follow-up testing as directed by a health care provider (rather than subsequent follow-up testing as directed by a health care provider).